Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity
Authors
Keywords
-
Journal
CELL BIOLOGY AND TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-27
DOI
10.1007/s10565-023-09835-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PTX3 from vascular endothelial cells contributes to trastuzumab-induced cardiac complications
- (2023) Zhifei Xu et al. CARDIOVASCULAR RESEARCH
- ROS and iron homeostasis dependent ferroptosis play a vital role in 5-Fluorouracil induced cardiotoxicity in vitro and in vivo
- (2022) Dongning Li et al. TOXICOLOGY
- Generating 3D human cardiac constructs from pluripotent stem cells
- (2022) Chang Liu et al. EBioMedicine
- Transcriptome analysis of long noncoding RNAs reveals their potential roles in anthracycline-induced cardiotoxicity
- (2022) Nhan Nguyen et al. Non-coding RNA Research
- Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
- (2022) Akshay Narkar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A multi-organ chip with matured tissue niches linked by vascular flow
- (2022) Kacey Ronaldson-Bouchard et al. Nature Biomedical Engineering
- Cancer treatment and survivorship statistics, 2022
- (2022) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Involvement of kallikrein‐PAR2‐proinflammatory pathway in severe trastuzumab‐induced cardiotoxicity
- (2022) Ritsuko Sasaki et al. CANCER SCIENCE
- Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
- (2022) Sofija Vučković et al. Stem Cell Research & Therapy
- Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies
- (2022) Sanne de Wit et al. CARDIOVASCULAR RESEARCH
- Use of Human iPSC-CMs in Nonclinical Regulatory Studies for Cardiac Safety Assessment
- (2022) Xi Yang et al. TOXICOLOGICAL SCIENCES
- Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform
- (2022) Roberta Visone et al. TOXICOLOGICAL SCIENCES
- Investigating and Resolving Cardiotoxicity Induced by COVID‐19 Treatments using Human Pluripotent Stem Cell‐Derived Cardiomyocytes and Engineered Heart Tissues
- (2022) He Xu et al. Advanced Science
- Temporal trends in the incidence of malignancy in heart failure: a nationwide Danish study
- (2022) Jonas Bruhn et al. EUROPEAN HEART JOURNAL
- Cellular and Molecular Mechanisms of MEK1 Inhibitor–Induced Cardiotoxicity
- (2022) Tyler C. Beck et al. JACC: CardioOncology
- Bioprinting 3D human cardiac tissue chips using the pin type printer “Microscopic painting device” and analysis for cardiotoxicity
- (2021) Shohei Chikae et al. Biomedical Materials
- Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
- (2021) A. D. Podgurskaya et al. Scientific Reports
- Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases
- (2021) Valentina Paloschi et al. CARDIOVASCULAR RESEARCH
- The Leading Causes of Death in the US for 2020
- (2021) Farida B. Ahmad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells
- (2021) Giulia Campostrini et al. Nature Protocols
- Bevacizumab-Induced Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and ERK Inactivation Contribute to Cardiotoxicity
- (2021) Yue Li et al. Oxidative Medicine and Cellular Longevity
- A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues
- (2021) Celinda M. Kofron et al. Scientific Reports
- Dexmedetomidine exhibits antiarrhythmic effects on human-induced pluripotent stem cell-derived cardiomyocytes through a Na/Ca channel-mediated mechanism
- (2021) Li Yang et al. Annals of Translational Medicine
- Assessing the influence of perfusion on cardiac microtissue maturation: A heart‐on‐chip platform embedding peristaltic pump capabilities
- (2021) Daniela Cruz‐Moreira et al. BIOTECHNOLOGY AND BIOENGINEERING
- From Studying Heart Disease and Cancer Simultaneously to Reverse Cardio-Oncology
- (2021) Sanne de Wit et al. CIRCULATION
- Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
- (2021) Lars Michel et al. EUROPEAN HEART JOURNAL
- Multicellular Human Cardiac Organoids Transcriptomically Model Distinct Tissue-Level Features of Adult Myocardium
- (2021) Charles M. Kerr et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity
- (2021) Valerie Sapp et al. Scientific Reports
- Translational Proteomics Analysis of Anthracycline-Induced Cardiotoxicity From Cardiac Microtissues to Human Heart Biopsies
- (2021) Nhan Nguyen et al. Frontiers in Genetics
- An Extensive Metabolomics Workflow to Discover Cardiotoxin-Induced Molecular Perturbations in Microtissues
- (2021) Tara J. Bowen et al. Metabolites
- Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification
- (2021) Carmen Bergom et al. JACC: CardioOncology
- Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity
- (2021) Tarek Magdy et al. CIRCULATION
- Dynamic observation of 5‑fluorouracil‑induced myocardial injury and mitochondrial autophagy in aging rats
- (2021) Yuanyang Li et al. Experimental and Therapeutic Medicine
- Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
- (2021) Parvin Forghani et al. Journal of the American Heart Association
- Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells
- (2021) Jian-an Pan et al. Redox Biology
- From Shape to Function: The Next Step in Bioprinting
- (2020) Riccardo Levato et al. ADVANCED MATERIALS
- Heart-on-a-chip Model with Integrated Extra- and Intra-cellular Bioelectronics for Monitoring Cardiac Electrophysiology under Acute Hypoxia
- (2020) Haitao Liu et al. NANO LETTERS
- Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease
- (2020) Elisa Giacomelli et al. Cell Stem Cell
- Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a Position Statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society
- (2020) Alexander R. Lyon et al. EUROPEAN JOURNAL OF HEART FAILURE
- Recent Applications of Three Dimensional Printing in Cardiovascular Medicine
- (2020) Chiara Gardin et al. Cells
- Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity
- (2020) Dylan J. Richards et al. Nature Biomedical Engineering
- Circulating high-sensitivity troponin T and microRNAs as markers of myocardial damage during childhood leukaemia treatment
- (2020) Yiu-fai Cheung et al. PEDIATRIC RESEARCH
- Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes
- (2020) Dries A.M. Feyen et al. Cell Reports
- Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity
- (2020) Tomonori Tadokoro et al. JCI Insight
- Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity
- (2020) Wesley L. McKeithan et al. Cell Stem Cell
- Crosstalk Between the Heart and Cancer
- (2020) Javid Moslehi et al. CIRCULATION
- Xanthine oxidase inhibition attenuates doxorubicin-induced cardiotoxicity in mice
- (2020) Yoshiro Tanaka et al. FREE RADICAL BIOLOGY AND MEDICINE
- Endothelial extracellular vesicles contain protective proteins and rescue ischemia-reperfusion injury in a human heart-on-chip
- (2020) Moran Yadid et al. Science Translational Medicine
- A Heart‐Breast Cancer‐on‐a‐Chip Platform for Disease Modeling and Monitoring of Cardiotoxicity Induced by Cancer Chemotherapy
- (2020) Junmin Lee et al. Small
- Human Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Breast Cancer Patients
- (2019) Tomoya Kitani et al. CIRCULATION
- A Human iPSC Double-Reporter System Enables Purification of Cardiac Lineage Subpopulations with Distinct Function and Drug Response Profiles
- (2019) Joe Z. Zhang et al. Cell Stem Cell
- A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
- (2019) Yimu Zhao et al. CELL
- Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications
- (2019) Idit Goldfracht et al. Acta Biomaterialia
- User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip
- (2019) Oliver Schneider et al. TISSUE ENGINEERING PART A
- FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT
- (2019) Xin Zhang et al. CELL DEATH AND DIFFERENTIATION
- Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery
- (2019) Nicole T Feric et al. TOXICOLOGICAL SCIENCES
- Cardiotoxicity of sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis
- (2019) Wenzhuo Ma et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Neonatal murine engineered cardiac tissue toxicology model: Impact of dexrazoxane on doxorubicin induced injury
- (2019) Juan Zhen et al. LIFE SCIENCES
- Human Induced Pluripotent Stem-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anticancer Efficacy and Cardiotoxicity
- (2019) Kuo-Chan Weng et al. TISSUE ENGINEERING PART C-METHODS
- Early Vascular Cells Improve Microvascularization Within 3D Cardiac Spheroids
- (2019) Isaree Pitaktong et al. TISSUE ENGINEERING PART C-METHODS
- Effects of acrolein in comparison to its prodrug cyclophosphamide on human primary endothelial cells in vitro
- (2019) S. Lau et al. TOXICOLOGY IN VITRO
- Inhibition of Radiation-Induced Ccl2 Signaling Protects Lungs from Vascular Dysfunction and Endothelial Cell Loss
- (2018) Alina Wiesemann et al. ANTIOXIDANTS & REDOX SIGNALING
- Isolation and characterization of ventricular-like cells derived from NKX2-5 eGFP/w and MLC2v mCherry/w double knock-in human pluripotent stem cells
- (2018) Kaori Yamauchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Human Induced Pluripotent Stem Cell–Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers
- (2018) Marc D. Lemoine et al. Circulation-Arrhythmia and Electrophysiology
- Advanced maturation of human cardiac tissue grown from pluripotent stem cells
- (2018) Kacey Ronaldson-Bouchard et al. NATURE
- Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies
- (2018) Naim Shaheen et al. Stem Cell Reports
- Obesity and cancer risk: Emerging biological mechanisms and perspectives
- (2018) Konstantinos I. Avgerinos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Use of human induced pluripotent stem cell–derived cardiomyocytes to assess drug cardiotoxicity
- (2018) Arun Sharma et al. Nature Protocols
- High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells
- (2017) Arun Sharma et al. Science Translational Medicine
- Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae
- (2017) Ingra Mannhardt et al. TOXICOLOGICAL SCIENCES
- A COUP-TFII Human Embryonic Stem Cell Reporter Line to Identify and Select Atrial Cardiomyocytes
- (2017) Verena Schwach et al. Stem Cell Reports
- Cardiac spheroids as promising in vitro models to study the human heart microenvironment
- (2017) Liudmila Polonchuk et al. Scientific Reports
- Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip
- (2016) Yu Shrike Zhang et al. BIOMATERIALS
- Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues
- (2016) Anna Marsano et al. LAB ON A CHIP
- Recombinant human neuregulin-1β is protective against radiation-induced myocardial cell injury
- (2016) QIANG ZHOU et al. Molecular Medicine Reports
- Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker
- (2016) Stephanie I Protze et al. NATURE BIOTECHNOLOGY
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
- (2016) Paul W Burridge et al. NATURE MEDICINE
- Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches
- (2015) Kenji Miki et al. Cell Stem Cell
- Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology
- (2015) H. D. Devalla et al. EMBO Molecular Medicine
- Burgeoning Cardio-Oncology Programs
- (2015) Tochi M. Okwuosa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells
- (2015) Matthew J Birket et al. NATURE BIOTECHNOLOGY
- Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells
- (2015) Gustav Holmgren et al. TOXICOLOGY
- SHOX2 Overexpression Favors Differentiation of Embryonic Stem Cells into Cardiac Pacemaker Cells, Improving Biological Pacing Ability
- (2015) Vittoria Ionta et al. Stem Cell Reports
- Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes
- (2015) Chiara Focaccetti et al. PLoS One
- Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
- (2014) Gang Wang et al. NATURE MEDICINE
- Chemically defined generation of human cardiomyocytes
- (2014) Paul W Burridge et al. NATURE METHODS
- Programming and Isolation of Highly Pure Physiologically and Pharmacologically Functional Sinus-Nodal Bodies from Pluripotent Stem Cells
- (2014) Julia Jeannine Jung et al. Stem Cell Reports
- Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes
- (2013) Alexandra Bizy et al. Stem Cell Research
- Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
- (2012) Shugo Tohyama et al. Cell Stem Cell
- Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions
- (2012) Xiaojun Lian et al. Nature Protocols
- Cozzarelli Prize Winner: Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling
- (2012) X. Lian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stage-Specific Optimization of Activin/Nodal and BMP Signaling Promotes Cardiac Differentiation of Mouse and Human Pluripotent Stem Cell Lines
- (2011) Steven J. Kattman et al. Cell Stem Cell
- SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells
- (2011) Nicole C Dubois et al. NATURE BIOTECHNOLOGY
- NKX2-5 eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes
- (2011) David A Elliott et al. NATURE METHODS
- Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression
- (2011) Hideki Uosaki et al. PLoS One
- Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals
- (2010) Qiangzhe Zhang et al. CELL RESEARCH
- Nongenetic method for purifying stem cell–derived cardiomyocytes
- (2009) Fumiyuki Hattori et al. NATURE METHODS
- Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
- (2008) Lei Yang et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More